" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pamela M. McInnes Named NCATS Deputy Director

Published: Wednesday, December 04, 2013
Last Updated: Wednesday, December 04, 2013
Bookmark and Share
McInnes will join National Center for Advancing Translational Sciences in January 2014.

Pamela M. McInnes, D.D.S., has been named deputy director of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health.

McInnes currently serves as director of the Division of Extramural Research at the National Institute of Dental and Craniofacial Research (NIDCR). She will join NCATS in January 2014.

"I am thrilled that Pamela is joining the NCATS leadership team. Her expertise in translational and clinical research coupled with her extensive extramural management experience, and her record of accomplishment in trans-NIH and public-private collaborations, make her an ideal fit as our deputy director," said NCATS Director Christopher P. Austin, M.D.

Austin continued, "Her recruitment is a key milestone in our building the NCATS organization into a catalyst for transformational change in translational science, getting new treatments to more patients more quickly."

At NIDCR, McInnes was responsible for all of the institute's extramural research, which ranges from basic through clinical research, including large and complex clinical and population-based trials. She is committed to the rigorous and robust conduct of clinical trials that adhere to the highest standards for human subject protection and data integrity.

Her work in translational sciences has led to numerous product development and clinical evaluation programs, and she is involved actively with the broader extramural research community in efforts to reduce morbidity and mortality attributable to a large spectrum of diseases and disorders.

"I am excited to join NCATS, which is uniquely focused on solving translational process problems that aren't a primary focus of disease-oriented programs," McInnes said. "I look forward to collaborating with stakeholders in the government, academia, patient organizations and the private sector to revolutionize the way translational research is conducted nationwide."

Prior to her time at NIDCR, McInnes spent 16 years at the NIH's National Institute of Allergy and Infectious Diseases (NIAID), where she served in many capacities, including deputy director for its Division of Microbiology and Infectious Diseases.

In this role, she oversaw extramural research branch programs in infectious diseases and microbiology. She concurrently served as associate director for clinical research and had responsibility for the reorganization and oversight of the complex and diverse Divisional Clinical Research Program.

Her work on contract awards to develop recombinant RPA anthrax vaccines and attenuated smallpox vaccines required extensive collaboration and interactions with the Food and Drug Administration, Department of Defense, and Centers for Disease Control and Prevention.

Another of her many accomplishments at NIAID was oversight of the scientific design and programmatic implementation of its Challenge Grant Program.

The goal of this initiative was to promote joint ventures between NIH and biotechnology, pharmaceutical and medical device industries to reduce significantly the impact of infectious diseases nationally and worldwide.

The author of more than 40 peer-reviewed articles and five books, McInnes first joined NIH in 1989 as a grants associate for its Office of Extramural Programs in the Office of the Director.

Before coming to NIH, she served in academic and consulting roles at the Louisiana State University Medical Center, Shreveport.

McInnes earned her D.D.S. and M.S. degrees from the University of the Witwatersrand, in Johannesburg, where she also lectured prior to coming to the United States.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Monday, February 08, 2016
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Friday, February 05, 2016
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Thursday, February 04, 2016
Genome-Wide Study Yields Markers of Lithium Response
An international consortium of scientists has identified a stretch of chromosome that is associated with responsiveness to the mood-stabilizing medication lithium among patients with bipolar disorder.
Monday, February 01, 2016
Schizophrenia’s Strongest Known Genetic Risk Deconstructed
Suspect gene may trigger runaway synaptic pruning during adolescence – NIH-funded study.
Thursday, January 28, 2016
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
Monday, January 25, 2016
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Friday, January 15, 2016
NIH Genome Sequencing Program Targets the Genomic Bases of Common, Rare Disease
The National Institutes of Health will fund a set of genome sequencing and analysis centers whose research will focus on understanding the genomic bases of common and rare human diseases.
Friday, January 15, 2016
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
Wednesday, January 13, 2016
Three Glaucoma-Related Genes Discovered
NIH-funded genetics analysis of glaucoma is largest to date.
Tuesday, January 12, 2016
NIH-funded Memory Drug Moves into Phase 1 Clinical Study
Collaboration between NIH and Tetra Discovery Partners leads to development of treatment that may affect cognition.
Monday, January 04, 2016
International Study Reveals New Genetic Clues to AMD
NIH-funded research provides framework for future studies of AMD biology, therapy.
Tuesday, December 22, 2015
NIH Unveils FY2016–2020 Strategic Plan
Detailed plan sets course for advancing scientific discoveries and human health.
Thursday, December 17, 2015
Biomarkers Outperform Symptoms in Parsing Psychosis Subgroups
Multiple biological pathways lead to similar symptoms - NIH-funded study.
Thursday, December 10, 2015
Researchers Investigate How a Developing Brain is Assembled
NIH 3-D software tracks worm embryo's brain development.
Tuesday, December 08, 2015
Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!